🎉 M&A multiples are live!
Check it out!

NIOX Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for NIOX Group and similar public comparables like SmartVest, InfuSystem, and Myomo.

NIOX Group Overview

About NIOX Group

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.


Founded

2006

HQ

United Kingdom of Great Britain and Northern Ireland
Employees

91

Website

niox.com

Financials

LTM Revenue $58.0M

LTM EBITDA $18.9M

EV

$314M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

NIOX Group Financials

NIOX Group has a last 12-month revenue of $58.0M and a last 12-month EBITDA of $18.9M.

In the most recent fiscal year, NIOX Group achieved revenue of $55.7M and an EBITDA of $16.1M.

NIOX Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See NIOX Group valuation multiples based on analyst estimates

NIOX Group P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $49.0M $55.7M XXX XXX XXX
Gross Profit $29.6M $35.3M XXX XXX XXX
Gross Margin 60% 63% XXX XXX XXX
EBITDA $11.5M $16.1M XXX XXX XXX
EBITDA Margin 23% 29% XXX XXX XXX
Net Profit $21.5M $14.3M XXX XXX XXX
Net Margin 44% 26% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

NIOX Group Stock Performance

As of May 1, 2025, NIOX Group's stock price is GBP 1 (or $1).

NIOX Group has current market cap of GBP 245M (or $327M), and EV of GBP 236M (or $314M).

See NIOX Group trading valuation data

NIOX Group Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$314M $327M XXX XXX XXX XXX $0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

NIOX Group Valuation Multiples

As of May 1, 2025, NIOX Group has market cap of $327M and EV of $314M.

NIOX Group's trades at 5.4x LTM EV/Revenue multiple, and 16.6x LTM EBITDA.

Analysts estimate NIOX Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for NIOX Group and 10K+ public comps

NIOX Group Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $314M XXX XXX XXX
EV/Revenue 5.6x XXX XXX XXX
EV/EBITDA 19.5x XXX XXX XXX
P/E 66.3x XXX XXX XXX
P/E/Growth 0.7x XXX XXX XXX
EV/FCF 14.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get NIOX Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

NIOX Group Valuation Multiples

NIOX Group's NTM/LTM revenue growth is 12%

NIOX Group's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, NIOX Group's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate NIOX Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for NIOX Group and other 10K+ public comps

NIOX Group Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 14% XXX XXX XXX XXX
EBITDA Margin 29% XXX XXX XXX XXX
EBITDA Growth 41% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 41% XXX XXX XXX XXX
Revenue per Employee $0.6M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue 27% XXX XXX XXX XXX
G&A Expenses to Revenue 21% XXX XXX XXX XXX
R&D Expenses to Revenue 6% XXX XXX XXX XXX
Opex to Revenue 54% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms
Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS

NIOX Group Public Comps

See public comps and valuation multiples for Medical Devices and Medical Imaging & Diagnostics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

NIOX Group M&A and Investment Activity

NIOX Group acquired  XXX companies to date.

Last acquisition by NIOX Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . NIOX Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by NIOX Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About NIOX Group

When was NIOX Group founded? NIOX Group was founded in 2006.
Where is NIOX Group headquartered? NIOX Group is headquartered in United Kingdom of Great Britain and Northern Ireland.
How many employees does NIOX Group have? As of today, NIOX Group has 91 employees.
Who is the CEO of NIOX Group? NIOX Group's CEO is Mr. Jonathan Charles Emms.
Is NIOX Group publicy listed? Yes, NIOX Group is a public company listed on LON.
What is the stock symbol of NIOX Group? NIOX Group trades under NIOX ticker.
When did NIOX Group go public? NIOX Group went public in 2014.
Who are competitors of NIOX Group? Similar companies to NIOX Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of NIOX Group? NIOX Group's current market cap is $327M
What is the current revenue of NIOX Group? NIOX Group's last 12-month revenue is $58.0M.
What is the current EBITDA of NIOX Group? NIOX Group's last 12-month EBITDA is $18.9M.
What is the current EV/Revenue multiple of NIOX Group? Current revenue multiple of NIOX Group is 5.4x.
What is the current EV/EBITDA multiple of NIOX Group? Current EBITDA multiple of NIOX Group is 16.6x.
What is the current revenue growth of NIOX Group? NIOX Group revenue growth between 2023 and 2024 was 14%.
Is NIOX Group profitable? Yes, NIOX Group is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.